Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases.
about
New insights into sodium transport regulation in the distal nephron: Role of G-protein coupled receptorsPodocyte pathology and nephropathy - sphingolipids in glomerular diseasesSphingosine Kinase 2 Deficiency Attenuates Kidney Fibrosis via IFN-γ.Implication of sphingosin-1-phosphate in cardiovascular regulation.Biglycan- and Sphingosine Kinase-1 Signaling Crosstalk Regulates the Synthesis of Macrophage Chemoattractants.Two faces of inflammation: an immunopharmacological view.Resveratrol and its oligomers: modulation of sphingolipid metabolism and signaling in disease.Platelet-derived sphingosine-1-phosphate and inflammation: from basic mechanisms to clinical implications.Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance.Challenges to develop novel anti-inflammatory and analgesic drugs.Activation of S1P₁ receptor regulates PI3K/Akt/FoxO3a pathway in response to oxidative stress in PC12 cells.Sphingosine-1-phosphate transporters as targets for cancer therapy.Sphingolipids and Redox Signaling in Renal Regulation and Chronic Kidney Diseases.Resveratrol Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis through C3aR/C5aR- Sphingosine Kinase 1 Pathway.Downregulation of the S1P Transporter Spinster Homology Protein 2 (Spns2) Exerts an Anti-Fibrotic and Anti-Inflammatory Effect in Human Renal Proximal Tubular Epithelial Cells.
P2860
Q26765204-FA43E3DB-83C0-450D-8240-ABBDCC0D7EDDQ26852463-7584DB9B-61A2-4B33-BA16-E8CBD5B409C1Q30275552-12DF092D-A7A6-47D0-AA15-A20C7CF69656Q36898368-A461D8A4-C36B-43BC-9F06-69700992990FQ37729228-C14E8838-EAF9-48C3-BB25-2A71425A67BBQ38167040-8182C5B4-4E6C-4AF9-BB00-8100406C6F40Q38262594-537949F3-6CC2-4947-8AA3-467CE7BBF8BBQ38763707-FE54C87A-3661-4C59-8A60-3D348E4F3303Q38833111-BEDD31DC-6356-4489-8518-BEB87A6F73CAQ38941483-E16DC756-8E52-4E42-8637-27FDC277AA3AQ41656417-AAFE7AD7-350F-45DA-B7EE-82C0783579C9Q42181059-DCEEFA8A-0569-40FB-8D49-9FD670B62C96Q45072496-B98945BC-31A9-4DD4-A5C8-A018509FEC07Q54151193-BC222685-1738-42B0-A764-2084EB812A6FQ54978854-5B4CBB62-9BB6-47B0-B6FF-2FC8952E20B2
P2860
Targeting the sphingosine kinase/sphingosine 1-phosphate pathway to treat chronic inflammatory kidney diseases.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting the sphingosine kina ...... inflammatory kidney diseases.
@en
type
label
Targeting the sphingosine kina ...... inflammatory kidney diseases.
@en
prefLabel
Targeting the sphingosine kina ...... inflammatory kidney diseases.
@en
P2093
P2860
P356
P1476
Targeting the sphingosine kina ...... inflammatory kidney diseases.
@en
P2093
Andrea Huwiler
Josef Pfeilschifter
Stephanie Schwalm
P2860
P356
10.1111/BCPT.12103
P577
2013-07-15T00:00:00Z